<tmx version="1.4">
 <header adminlang="LC" srclang="en" o-tmf="PlainText" creationtool="bitextor" creationtoolversion="8.2" datatype="PlainText" segtype="sentence" creationdate="20221217T014330" o-encoding="utf-8">
 </header>
 <body>
   <tu tuid="1" datatype="Text">
    <prop type="score-hunalign">1.84301</prop>
    <prop type="score-bicleaner">0.622</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final_210329_%20English_NAFKAM%20strategic%20plan%202021_2025%20%28003%29_0.pdf.converted</prop>
     <seg>Although the Danish information center on CAM3 was closed in 2013, there continues to be a high need and interest among patient organizations and political parties in Denmark for a national knowledge center on CAM and collaboration with NAFKAM therein4.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final%20text_210329%20Norwegian%20Strategic%20Plan%202021_2025%20%28002%29_0.pdf.converted</prop>
     <seg>Selv om det danske senteret om CAM3 ble stengt allerede i 2013, er det fortsatt et stort behov og interesse blant pasientorganisasjoner og politiske partier i Danmark for et nasjonalt kunnskapssenter og samarbeid med NAFKAM4.</seg>
    </tuv>
   </tu>
   <tu tuid="2" datatype="Text">
    <prop type="score-hunalign">1.90202</prop>
    <prop type="score-bicleaner">0.616</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/contact-information/who-collaborating-centre</prop>
     <seg>At the occasion of its most recent redesignation in 2020, the past and current director of NAFKAM as well as the WHO regional director for Europe recount twelve successful years and praise the collaboration:</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/contact-information/who-samarbeidssenter</prop>
     <seg>I anledning den siste utnevnelsen i 2020, forteller NAFKAMs n&#229;v&#230;rende og forrige direkt&#248;rer, samt WHOs regionale direkt&#248;r for Europa om tolv vellykkede &#229;r, og roser samarbeidet:</seg>
    </tuv>
   </tu>
   <tu tuid="3" datatype="Text">
    <prop type="score-hunalign">1.62</prop>
    <prop type="score-bicleaner">0.642</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>&#8226; On average, this group spent almost NOK 1000 each on dietary supplements last year. This</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>&#8226; Gjennomsnittlig brukte denne gruppen nesten 1000 kr hver p&#229; slike tilskudd i fjor. Dette var en</seg>
    </tuv>
   </tu>
   <tu tuid="4" datatype="Text">
    <prop type="score-hunalign">1.03636</prop>
    <prop type="score-bicleaner">0.650</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/contact-information/who-collaborating-centre</prop>
     <seg>Reflections and outlook</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/contact-information/who-samarbeidssenter</prop>
     <seg>Refleksjoner og utsikter</seg>
    </tuv>
   </tu>
   <tu tuid="5" datatype="Text">
    <prop type="score-hunalign">2.46039</prop>
    <prop type="score-bicleaner">0.588</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/lifestyle-changes-during-covid-19-pandemic</prop>
     <seg>The large impact of the COVID-19 pandemic might motivate people to stay healthy and adopt a healthier lifestyle.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/livsstilsendringer-under-covid-19-pandemien</prop>
     <seg>Den store effekten av COVID-19-pandemien kan motivere personer til &#229; holde seg sunne og ta til seg en sunnere livsstil.</seg>
    </tuv>
   </tu>
   <tu tuid="6" datatype="Text">
    <prop type="score-hunalign">6.77</prop>
    <prop type="score-bicleaner">0.536</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>was a cost increase of 7%.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>kostnads&#248;kning p&#229; 7%.</seg>
    </tuv>
   </tu>
   <tu tuid="7" datatype="Text">
    <prop type="score-hunalign">1.00767</prop>
    <prop type="score-bicleaner">0.576</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final_210329_%20English_NAFKAM%20strategic%20plan%202021_2025%20%28003%29_0.pdf.converted</prop>
     <seg>The research team performs studies to investigate the effectiveness and safety of CAM and acts externally as CAM experts based on their scientific competence.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final%20text_210329%20Norwegian%20Strategic%20Plan%202021_2025%20%28002%29_0.pdf.converted</prop>
     <seg>Informasjonsavdelingen arbeider hovedsakelig med all formidling av informasjon om alternativ behandling, og forskerne som er den vitenskapelige kompetanse.</seg>
    </tuv>
   </tu>
   <tu tuid="8" datatype="Text">
    <prop type="score-hunalign">2.57948</prop>
    <prop type="score-bicleaner">0.680</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final_210329_%20English_NAFKAM%20strategic%20plan%202021_2025%20%28003%29_0.pdf.converted</prop>
     <seg>Photo 3 Illustrative example of an education meeting co-organized by NAFKAM on self-use of CAM.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final%20text_210329%20Norwegian%20Strategic%20Plan%202021_2025%20%28002%29_0.pdf.converted</prop>
     <seg>Foto 3 Illustrasjonsbilde p&#229; et utdanningsm&#248;te som ble organisert av NAFKAM om selvbruk av CAM.</seg>
    </tuv>
   </tu>
   <tu tuid="9" datatype="Text">
    <prop type="score-hunalign">2.0597</prop>
    <prop type="score-bicleaner">0.582</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/or-outside-box-integrative-healthcare-netherlands</prop>
     <seg>It was apparent that over 25% of the European population use some form of complementary and alternative medicine, and little to no central regulation on this.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/innenfor-eller-utenfor-boksen-integrativ-behandling-i-nederland</prop>
     <seg>Det kom frem at over 25 % av den europeiske befolkningen bruker en eller annen form for komplement&#230;r og alternativ medisin, og at det er lite eller ingen sentral regulering av dette.</seg>
    </tuv>
   </tu>
   <tu tuid="10" datatype="Text">
    <prop type="score-hunalign">3.27647</prop>
    <prop type="score-bicleaner">0.588</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>37% had used one or more forms for CAM; once or several times.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>37% hadde brukt en el er flere former for alternativ behandling;</seg>
    </tuv>
   </tu>
   <tu tuid="11" datatype="Text">
    <prop type="score-hunalign">1.15364</prop>
    <prop type="score-bicleaner">0.626</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>services in Norway. The decline in the use of CAM that we saw in our surveys from 2012-14-16 seems to have</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>&#8226; Nedgangen som vi s&#229; i bruken av alternativ behandling fra 2012-14-16 ser ut til &#229; ha flatet ut.</seg>
    </tuv>
   </tu>
   <tu tuid="12" datatype="Text">
    <prop type="score-hunalign">3.2962</prop>
    <prop type="score-bicleaner">0.600</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/lifestyle-changes-during-covid-19-pandemic</prop>
     <seg>To determine life-style related changes during the first wave of the COVID-19 pandemic</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/livsstilsendringer-under-covid-19-pandemien</prop>
     <seg>&#197; fastsl&#229; livsstilsrelaterte endringer under den f&#248;rste b&#248;lgen av COVID-19-pandemien</seg>
    </tuv>
   </tu>
   <tu tuid="13" datatype="Text">
    <prop type="score-hunalign">3.99284</prop>
    <prop type="score-bicleaner">0.590</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>Slightly more women (12%) than men (8%) stated that they</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>Litt flere kvinner (12%) enn menn (8%) oppga &#229; ha brukt</seg>
    </tuv>
   </tu>
   <tu tuid="14" datatype="Text">
    <prop type="score-hunalign">1.10904</prop>
    <prop type="score-bicleaner">0.584</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Attachment%20to%20NAFKAMs%20strategic%20plan%202021_2025.pdf.converted</prop>
     <seg>&#8226; WHO-oriented, should be more oriented to the Nordic and other comparable countries &#8226; Sneak-promotion of CAM, not daring to say &#8220;it does not work&#8221; &#8226; Located under UIT, which hinders NAFKAMs ability of being individual and free in decisions,</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Vedlegg%20til%20NAFKAMs%20strategiske%20plan%202021_2025.pdf.converted</prop>
     <seg>&#8226; WHO-orientert, burde v&#230;re mer orientert mot Norden og sammenlignbare land &#8226; Snik-promotering av alternativ behandling, har ikke mot til &#229; si &#171;det virker ikke&#187; &#8226; Tilh&#248;righet under UiT, noe som begrenser NAFKAMs evne til egne avgj&#248;relser og bruk av nye</seg>
    </tuv>
   </tu>
   <tu tuid="15" datatype="Text">
    <prop type="score-hunalign">1.79871</prop>
    <prop type="score-bicleaner">0.630</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/contact-information/who-collaborating-centre</prop>
     <seg>Declaration on Universal Health Coverage in 2019, includes a commitment to</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/contact-information/who-samarbeidssenter</prop>
     <seg>FNs politiske erkl&#230;ring om universell helsedekning i 2019, inkluderer en forpliktelse til &#229;</seg>
    </tuv>
   </tu>
   <tu tuid="16" datatype="Text">
    <prop type="score-hunalign">1.1125</prop>
    <prop type="score-bicleaner">0.606</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>appointments for learning such techniques.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>bruk av mentale teknikker.</seg>
    </tuv>
   </tu>
   <tu tuid="17" datatype="Text">
    <prop type="score-hunalign">1.63103</prop>
    <prop type="score-bicleaner">0.632</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/or-outside-box-integrative-healthcare-netherlands</prop>
     <seg>NAFKAM&#8217;s Miek Jong and Barbara Wider recently attended the</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/innenfor-eller-utenfor-boksen-integrativ-behandling-i-nederland</prop>
     <seg>NAFKAMs Miek Jong og Barbara Wider deltok nylig p&#229; den</seg>
    </tuv>
   </tu>
   <tu tuid="18" datatype="Text">
    <prop type="score-hunalign">2.66842</prop>
    <prop type="score-bicleaner">0.588</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/sencancer</prop>
     <seg>The data is mainly based on repeated interviews and participant observation with 10 people over a period of 11 months.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sencancer</prop>
     <seg>Dataene baserer seg i hovedsak p&#229; gjentakende intervjuer og deltakende observasjon med 10 personer over 11 m&#229;neder.</seg>
    </tuv>
   </tu>
   <tu tuid="19" datatype="Text">
    <prop type="score-hunalign">1.31122</prop>
    <prop type="score-bicleaner">0.642</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>This was an increase by 12% from 2016, and the increase was greatest among men.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>&#8226; Kostnadene til dette gikk opp med 12% fra 2016, og kostnads&#248;kningen var st&#248;rst blant menn.</seg>
    </tuv>
   </tu>
   <tu tuid="20" datatype="Text">
    <prop type="score-hunalign">2.55238</prop>
    <prop type="score-bicleaner">0.568</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>The "average user" of CAM was female, over 40 years of age, with</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>alternativ behandling var kvinne, over 40 &#229;r, med h&#248;y utdanning og h&#248;y inntekt, bosatt i eller</seg>
    </tuv>
   </tu>
   <tu tuid="21" datatype="Text">
    <prop type="score-hunalign">1.12683</prop>
    <prop type="score-bicleaner">0.640</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>The increases also appear to be greater than the</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>&#216;kningene ser ogs&#229; ut til &#229; v&#230;re st&#248;rre enn prisstigningen.</seg>
    </tuv>
   </tu>
   <tu tuid="22" datatype="Text">
    <prop type="score-hunalign">1.20692</prop>
    <prop type="score-bicleaner">0.578</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final_210329_%20English_NAFKAM%20strategic%20plan%202021_2025%20%28003%29_0.pdf.converted</prop>
     <seg>NAFKAM will furthermore actively participate in the Swedish Integrative Oncology Forum, a yearly two-day invitational conference organized by the Swedish Cancer Academy North in collaboration with the Regional Cancer Center Stockholm/Gotland.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final%20text_210329%20Norwegian%20Strategic%20Plan%202021_2025%20%28002%29_0.pdf.converted</prop>
     <seg>NAFKAM vil videre delta aktivt i Swedish Integrative Oncology Forum, som er en &#229;rlig to-dagers invitasjonskonferanse organisert av Swedish Cancer Academy North i samarbeid med Regionalt kreftsenter Stockholm / Gotland.</seg>
    </tuv>
   </tu>
   <tu tuid="23" datatype="Text">
    <prop type="score-hunalign">1.7971</prop>
    <prop type="score-bicleaner">0.568</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>This represents a smal increase from 2016 (+1 pp).</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>en eller flere ganger. &#8226; Dette var en liten &#248;kning fra 2016 (+1 pp).</seg>
    </tuv>
   </tu>
   <tu tuid="24" datatype="Text">
    <prop type="score-hunalign">4.42419</prop>
    <prop type="score-bicleaner">0.640</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>As before, more women (47%) than men</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>Som tidligere, var det flere kvinner (47%) enn menn</seg>
    </tuv>
   </tu>
   <tu tuid="25" datatype="Text">
    <prop type="score-hunalign">1.70142</prop>
    <prop type="score-bicleaner">0.654</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>being. We have no reason to believe that this changed in 2018.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>velv&#230;re, og finner ikke grunn til &#229; tro at dette endret seg i 2018.</seg>
    </tuv>
   </tu>
   <tu tuid="26" datatype="Text">
    <prop type="score-hunalign">2.88368</prop>
    <prop type="score-bicleaner">0.654</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>23% of al respondents had received one or more CAM therapies from CAM providers and/</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>23% av al e spurte hadde mottatt en eller flere alternative behandlingsformer fra behandler utenfor</seg>
    </tuv>
   </tu>
   <tu tuid="27" datatype="Text">
    <prop type="score-hunalign">2.38629</prop>
    <prop type="score-bicleaner">0.636</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/lifestyle-changes-during-covid-19-pandemic</prop>
     <seg>The questionnaire includes 26 question on current lifestyle related measures, lifestyle related changes since the COVID-19 outbreak, and intention to continue lifestyle changes and need for support.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/livsstilsendringer-under-covid-19-pandemien</prop>
     <seg>Sp&#248;rreskjemaet inneholder 26 sp&#248;rsm&#229;l om aktuelle livsstilsrelaterte tiltak, livsstilsrelaterte endringer siden COVID-19-utbruddet, og intensjon om &#229; fortsette livsstilsendringer og behov for st&#248;tte.</seg>
    </tuv>
   </tu>
   <tu tuid="28" datatype="Text">
    <prop type="score-hunalign">2.56842</prop>
    <prop type="score-bicleaner">0.608</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>This survey shows that the use of CAM in Norway remained at a high level in 2018:</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>Denne unders&#248;kelsen viser at bruken av alternativ behandling i Norge fortsatt l&#229; p&#229; et h&#248;yt niv&#229; i 2018:</seg>
    </tuv>
   </tu>
   <tu tuid="29" datatype="Text">
    <prop type="score-hunalign">3.26087</prop>
    <prop type="score-bicleaner">0.562</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/american-researcher-nafkam</prop>
     <seg>Dana Catalina Mora (38) has recently moved from the USA to Troms&#248;, Norway, to work at NAFKAM.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/amerikansk-forsker-til-nafkam</prop>
     <seg>Dana Catalina Mora (38) har nylig flyttet fra USA til Troms&#248; for &#229; jobbe p&#229; NAFKAM.</seg>
    </tuv>
   </tu>
   <tu tuid="30" datatype="Text">
    <prop type="score-hunalign">3.09524</prop>
    <prop type="score-bicleaner">0.658</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/frauke-musial-takes-editor-chief-complementary-medicine-research</prop>
     <seg>I have been an associate editor with this journal since 2008, says Musial.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/frauke-musial-tar-over-som-sjefredaktor-tidsskrift</prop>
     <seg>- Jeg har v&#230;rt fagredakt&#248;r for dette tidsskriftet siden 2008, sier Musial.</seg>
    </tuv>
   </tu>
   <tu tuid="31" datatype="Text">
    <prop type="score-hunalign">1.14903</prop>
    <prop type="score-bicleaner">0.700</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Attachment%20to%20NAFKAMs%20strategic%20plan%202021_2025.pdf.converted</prop>
     <seg>High quality, internationally oriented.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Vedlegg%20til%20NAFKAMs%20strategiske%20plan%202021_2025.pdf.converted</prop>
     <seg>H&#248;y kvalitet, internasjonal orientering.</seg>
    </tuv>
   </tu>
   <tu tuid="32" datatype="Text">
    <prop type="score-hunalign">1.22666</prop>
    <prop type="score-bicleaner">0.570</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final_210329_%20English_NAFKAM%20strategic%20plan%202021_2025%20%28003%29_0.pdf.converted</prop>
     <seg>Many CAM users search for CAM information on the internet and buy CAM products and services online10.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final%20text_210329%20Norwegian%20Strategic%20Plan%202021_2025%20%28002%29_0.pdf.converted</prop>
     <seg>Mange brukere s&#248;ker etter informasjon p&#229; Internett, og kj&#248;per produkter og tjenester online10.</seg>
    </tuv>
   </tu>
   <tu tuid="33" datatype="Text">
    <prop type="score-hunalign">2.11846</prop>
    <prop type="score-bicleaner">0.678</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/lifestyle-changes-during-covid-19-pandemic</prop>
     <seg>On the other hand, the COVID-19 control measures such as social distancing and home isolation might increase sedentary behavior or unhealthy eating.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/livsstilsendringer-under-covid-19-pandemien</prop>
     <seg>P&#229; den andre siden kan kontrolltiltakene pga COVID-19, som sosial distansering og hjemmeisolasjon, muligens &#248;ke stillesittende atferd eller usunne spisevaner.</seg>
    </tuv>
   </tu>
   <tu tuid="34" datatype="Text">
    <prop type="score-hunalign">1.68934</prop>
    <prop type="score-bicleaner">0.636</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>&#8226; Respondents in this group each spent an average of NOK 3000 on such CAM. Distributed</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>&#8226; I denne gruppen brukte man i snitt vel 3000 kr hver p&#229; dette. Fordelt p&#229; hele befolkningen</seg>
    </tuv>
   </tu>
   <tu tuid="35" datatype="Text">
    <prop type="score-hunalign">2.3567</prop>
    <prop type="score-bicleaner">0.576</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final_210329_%20English_NAFKAM%20strategic%20plan%202021_2025%20%28003%29_0.pdf.converted</prop>
     <seg>In the past, employees working with information about CAM were working as a separate unit, NIFAB, which merged with NAFKAM in 2018.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final%20text_210329%20Norwegian%20Strategic%20Plan%202021_2025%20%28002%29_0.pdf.converted</prop>
     <seg>Tidligere var informasjonsvirksomheten organisert som en egen enhet (NIFAB), som fusjonerte med NAFKAM i 2018.</seg>
    </tuv>
   </tu>
   <tu tuid="36" datatype="Text">
    <prop type="score-hunalign">1.33487</prop>
    <prop type="score-bicleaner">0.650</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/american-researcher-nafkam</prop>
     <seg>The tool must contain reliable information about various strategies for self-care, including alternative treatments", said Dana Mora.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/amerikansk-forsker-til-nafkam</prop>
     <seg>Verkt&#248;yet skal inneholde p&#229;litelig informasjon om ulike strategier for egenomsorg, herunder alternative behandlinger, sier Dana Mora.</seg>
    </tuv>
   </tu>
   <tu tuid="37" datatype="Text">
    <prop type="score-hunalign">1.09824</prop>
    <prop type="score-bicleaner">0.620</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Attachment%20to%20NAFKAMs%20strategic%20plan%202021_2025.pdf.converted</prop>
     <seg>&#8226; Pandemics/ COVID infections will evolve and last for long &#8226; More fake health news about alleged health issues will be published, and more risky cures</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Vedlegg%20til%20NAFKAMs%20strategiske%20plan%202021_2025.pdf.converted</prop>
     <seg>&#8226; Pandemier /COVID vil utvikle og endre seg og vare lenge &#8226; Flere falske nyheter om p&#229;st&#229;tte helseutfordringer, flere risikofylte behandlinger vil komme</seg>
    </tuv>
   </tu>
   <tu tuid="38" datatype="Text">
    <prop type="score-hunalign">1.00594</prop>
    <prop type="score-bicleaner">0.632</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/nafkam-continues-cooperation-who</prop>
     <seg>The World Health Organization (WHO) has redesignated Norway&#8217;s National Research Center in Complementary and Alternative Medicine (NAFKAM) as a Collaborating Center for another four years.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/nafkam-fortsetter-samarbeidet-med-who</prop>
     <seg>Det er n&#229; klart at Verdens helseorganisasjon (WHO) fornyer avtalen med Nasjonalt Forskningssenter innenfor Komplement&#230;r og Alternativ Medisin (NAFKAM) med fire &#229;r.</seg>
    </tuv>
   </tu>
   <tu tuid="39" datatype="Text">
    <prop type="score-hunalign">1.97452</prop>
    <prop type="score-bicleaner">0.654</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/contact-information/who-collaborating-centre</prop>
     <seg>This resulted in three reports in 2012, as well as an online database providing open access to comprehensive legal and regulatory information on TCI in Europe (until December 2020).</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/contact-information/who-samarbeidssenter</prop>
     <seg>Dette resulterte i tre rapporter i 2012, samt en online database som ga &#229;pen tilgang til omfattende juridisk og forskriftsmessig informasjon om TCI i Europa (frem til desember 2020).</seg>
    </tuv>
   </tu>
   <tu tuid="40" datatype="Text">
    <prop type="score-hunalign">1.26007</prop>
    <prop type="score-bicleaner">0.572</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>Distributed onto the population, the cost of dietary supplements was approximately NOK 690 per person, and a total of just under NOK 3 bil ion.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>Fordelt p&#229; al e voksne nordmenn blir utgiftene til kosttilskudd ca 690 kr per person, og til sammen litt under 3 mrd kr.</seg>
    </tuv>
   </tu>
   <tu tuid="41" datatype="Text">
    <prop type="score-hunalign">1.11353</prop>
    <prop type="score-bicleaner">0.628</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/imcr-studie-integrated-medical-care-rehabiltation-study</prop>
     <seg>The rehabilitation project (IMCR study) has been developed for patients who have removed their amalgam fillings, but still experience health problems.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/imcr-studie-integrated-medical-care-rehabiltation</prop>
     <seg>Rehabiliteringsprosjektet (IMCR-studien) er utviklet for pasienter som har fjernet sine amalgamfyllinger, men fortsatt opplever helseplager.</seg>
    </tuv>
   </tu>
   <tu tuid="42" datatype="Text">
    <prop type="score-hunalign">1.27656</prop>
    <prop type="score-bicleaner">0.572</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final_210329_%20English_NAFKAM%20strategic%20plan%202021_2025%20%28003%29_0.pdf.converted</prop>
     <seg>&#8226; User statistics of NAFKAM&#8217;s website and other information/communication and</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final%20text_210329%20Norwegian%20Strategic%20Plan%202021_2025%20%28002%29_0.pdf.converted</prop>
     <seg>&#8226; Statistikk for bruken av NAFKAMs nettsteder og andre kommunikasjons- og</seg>
    </tuv>
   </tu>
   <tu tuid="43" datatype="Text">
    <prop type="score-hunalign">1.23462</prop>
    <prop type="score-bicleaner">0.602</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>leveled off. A closer look at what kinds of CAM were used in 2018 shows that:</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>Hvis vi ser n&#230;rmere p&#229; hva slags alternativ behandling som ble brukt i 2018, ser dette slik ut:</seg>
    </tuv>
   </tu>
   <tu tuid="44" datatype="Text">
    <prop type="score-hunalign">4.66364</prop>
    <prop type="score-bicleaner">0.618</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>&#8226; This was 2 pp more than in 2016.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>&#8226; Dette var 2 pp flere enn i 2016.</seg>
    </tuv>
   </tu>
   <tu tuid="45" datatype="Text">
    <prop type="score-hunalign">5.14643</prop>
    <prop type="score-bicleaner">0.664</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/contact-information/who-collaborating-centre</prop>
     <seg>WHO Traditional Medicine Strategy 2014-2023</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/contact-information/who-samarbeidssenter</prop>
     <seg>WHOs strategi for tradisjonell medisin 2014-2023</seg>
    </tuv>
   </tu>
   <tu tuid="46" datatype="Text">
    <prop type="score-hunalign">4.05818</prop>
    <prop type="score-bicleaner">0.608</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>This was a small increase of 3 pp from 2016.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>Dette var en &#248;kning p&#229; 3 pp fra 2016.</seg>
    </tuv>
   </tu>
   <tu tuid="47" datatype="Text">
    <prop type="score-hunalign">2.15938</prop>
    <prop type="score-bicleaner">0.672</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/frauke-musial-takes-editor-chief-complementary-medicine-research</prop>
     <seg>Registry of scientific publication channels ranked at level 1.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/frauke-musial-tar-over-som-sjefredaktor-tidsskrift</prop>
     <seg>er i Norges offisielle register over vitenskapelige publikasjonskanaler rangert p&#229; niv&#229; 1</seg>
    </tuv>
   </tu>
   <tu tuid="48" datatype="Text">
    <prop type="score-hunalign">1.0931</prop>
    <prop type="score-bicleaner">0.600</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/american-researcher-nafkam</prop>
     <seg>In this project, she is responsible for data collection, analysis work and dissemination of results.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/amerikansk-forsker-til-nafkam</prop>
     <seg>I prosjektet har hun ansvaret for datainnsamlingen, analysearbeidet og formidlingen av resultatene.</seg>
    </tuv>
   </tu>
   <tu tuid="49" datatype="Text">
    <prop type="score-hunalign">1.94342</prop>
    <prop type="score-bicleaner">0.604</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final_210329_%20English_NAFKAM%20strategic%20plan%202021_2025%20%28003%29_0.pdf.converted</prop>
     <seg>For example, NAFKAM recently initiated and performed an international cross-sectional survey with Sweden to investigate the use of CAM for prevention and treatment of COVID-19 related symptoms.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final%20text_210329%20Norwegian%20Strategic%20Plan%202021_2025%20%28002%29_0.pdf.converted</prop>
     <seg>For eksempel initierte og utf&#248;rte NAFKAM nylig en internasjonal tverrsnittsunders&#248;kelse med Sverige for &#229; unders&#248;ke bruken av CAM for forebygging og behandling av COVID-19-relaterte symptomer.</seg>
    </tuv>
   </tu>
   <tu tuid="50" datatype="Text">
    <prop type="score-hunalign">1.78235</prop>
    <prop type="score-bicleaner">0.710</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/or-outside-box-integrative-healthcare-netherlands</prop>
     <seg>CAM Cancer website</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/innenfor-eller-utenfor-boksen-integrativ-behandling-i-nederland</prop>
     <seg>nettsted CAM Cancer</seg>
    </tuv>
   </tu>
   <tu tuid="51" datatype="Text">
    <prop type="score-hunalign">3.53302</prop>
    <prop type="score-bicleaner">0.596</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>outside the health care system, they looked like this in 2018:</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>egenbehandling utenfor helsetjenesten, s&#229; dette slik ut i 2018:</seg>
    </tuv>
   </tu>
   <tu tuid="52" datatype="Text">
    <prop type="score-hunalign">1.12069</prop>
    <prop type="score-bicleaner">0.544</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final_210329_%20English_NAFKAM%20strategic%20plan%202021_2025%20%28003%29_0.pdf.converted</prop>
     <seg>educational meetings in close collaboration with patient and other public organizations in Norway.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final%20text_210329%20Norwegian%20Strategic%20Plan%202021_2025%20%28002%29_0.pdf.converted</prop>
     <seg>blant annet i sosiale medier, podcast og organiserte informasjons- og dialogm&#248;ter i samarbeid med pasientforeninger og relevante offentlige instanser i Norge.</seg>
    </tuv>
   </tu>
   <tu tuid="53" datatype="Text">
    <prop type="score-hunalign">1.11829</prop>
    <prop type="score-bicleaner">0.650</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/frauke-musial-takes-editor-chief-complementary-medicine-research</prop>
     <seg>I have full confidence that professor Musial as the new editor-in-chief will contribute to the excellence of this journal regarding its high-quality review process and publication of high-quality papers, says NAFKAMs Director, professor Miek Jong.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/frauke-musial-tar-over-som-sjefredaktor-tidsskrift</prop>
     <seg>- Jeg har full tillit til at professor Musial som ny sjefredakt&#248;r vil bidra til dette tidsskriftets fortreffelighet n&#229;r det gjelder h&#248;y kvalitet i gjennomg&#229;elsesprosessen av og publiseringen av forskningsartikler av h&#248;y kvalitet, sier NAFKAMs direkt&#248;r, professor Miek Jong.</seg>
    </tuv>
   </tu>
   <tu tuid="54" datatype="Text">
    <prop type="score-hunalign">1.465</prop>
    <prop type="score-bicleaner">0.606</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/contact-information/who-collaborating-centre</prop>
     <seg>To promote global communication and information exchange in the field of TCI.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/contact-information/who-samarbeidssenter</prop>
     <seg>&#197; fremme global kommunikasjon og informasjonsutveksling innen TCI.</seg>
    </tuv>
   </tu>
   <tu tuid="55" datatype="Text">
    <prop type="score-hunalign">4.79333</prop>
    <prop type="score-bicleaner">0.618</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>10% used herb / herbal remedies as self-treatment.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>10% brukte urter/ naturmidler som egenbehandling.</seg>
    </tuv>
   </tu>
   <tu tuid="56" datatype="Text">
    <prop type="score-hunalign">3.28916</prop>
    <prop type="score-bicleaner">0.606</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/contact-information/who-collaborating-centre</prop>
     <seg>NAFKAM was appointed by the World Health Organization as a WHO Collaborating Centre (WHOCC) in 2008.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/contact-information/who-samarbeidssenter</prop>
     <seg>NAFKAM ble utnevnt av Verdens Helseorganisasjon til et WHO Collaborating Center (WHOCC) i 2008.</seg>
    </tuv>
   </tu>
   <tu tuid="57" datatype="Text">
    <prop type="score-hunalign">1.56538</prop>
    <prop type="score-bicleaner">0.610</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/or-outside-box-integrative-healthcare-netherlands</prop>
     <seg>of the Dutch Consortium for Integrative Medicine and Health (CIZG).</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/innenfor-eller-utenfor-boksen-integrativ-behandling-i-nederland</prop>
     <seg>til det nederlandske konsortiet for integrativ medisin og helse (CIZG).</seg>
    </tuv>
   </tu>
   <tu tuid="58" datatype="Text">
    <prop type="score-hunalign">1.33714</prop>
    <prop type="score-bicleaner">0.692</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>abroad, at lower prices than over-the-counter in Norway.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>utlandet, til lavere priser enn i Norge.</seg>
    </tuv>
   </tu>
   <tu tuid="59" datatype="Text">
    <prop type="score-hunalign">1.13037</prop>
    <prop type="score-bicleaner">0.614</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final_210329_%20English_NAFKAM%20strategic%20plan%202021_2025%20%28003%29_0.pdf.converted</prop>
     <seg>Monitoring the effectiveness of self-use of CAM and the possible risks that are associated with this self-use as to ensure patient safety is a major challenge.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final%20text_210329%20Norwegian%20Strategic%20Plan%202021_2025%20%28002%29_0.pdf.converted</prop>
     <seg>Det er en stor utfordring &#229; overv&#229;ke effektiviteten av selvhjelp og egenbehandling, og mulige risikoer som er forbundet med slik behandling.</seg>
    </tuv>
   </tu>
   <tu tuid="60" datatype="Text">
    <prop type="score-hunalign">4.3298</prop>
    <prop type="score-bicleaner">0.530</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>17% stated that they had used self-help techniques as self-treatment.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>17% oppga &#229; ha brukt selvhjelpsteknikker som egenbehandling.</seg>
    </tuv>
   </tu>
   <tu tuid="61" datatype="Text">
    <prop type="score-hunalign">1.16472</prop>
    <prop type="score-bicleaner">0.666</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/nafkam-continues-cooperation-who</prop>
     <seg>WHO has 21 collaboration centers in traditional medicine and NAFKAM is one of two in Europe.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/nafkam-fortsetter-samarbeidet-med-who</prop>
     <seg>De har 21 samarbeidssentre innenfor tradisjonell medisin, og NAFKAM er ett av to i Europa. Nylig avg&#229;tt direkt&#248;r ved NAFKAM</seg>
    </tuv>
   </tu>
   <tu tuid="62" datatype="Text">
    <prop type="score-hunalign">1.00873</prop>
    <prop type="score-bicleaner">0.608</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final_210329_%20English_NAFKAM%20strategic%20plan%202021_2025%20%28003%29_0.pdf.converted</prop>
     <seg>The percentage of Norwegian citizens that use CAM as self-help, such as herbs, meditation and yoga to improve their health, are nowadays higher than those visiting a CAM provider/practitioner9.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final%20text_210329%20Norwegian%20Strategic%20Plan%202021_2025%20%28002%29_0.pdf.converted</prop>
     <seg>Andelen nordmenn som bruker alternativ behandling i form av selvhjelp, s&#229; som med urter, meditasjon og yoga for &#229; bevisst forbedre helsen, er i dag h&#248;yere enn de som mottar behandling fra en ut&#248;ver9.</seg>
    </tuv>
   </tu>
   <tu tuid="63" datatype="Text">
    <prop type="score-hunalign">1.47692</prop>
    <prop type="score-bicleaner">0.642</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/contact-information/who-collaborating-centre</prop>
     <seg>It is one of three WHOCC for Traditional, Complementary and Integrative Medicine (TCI) in Europe.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/contact-information/who-samarbeidssenter</prop>
     <seg>Vi er ett av tre WHOCC for tradisjonell, komplement&#230;r og integrativ medisin (TCI) i Europa.</seg>
    </tuv>
   </tu>
   <tu tuid="64" datatype="Text">
    <prop type="score-hunalign">1.45952</prop>
    <prop type="score-bicleaner">0.610</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/american-researcher-nafkam</prop>
     <seg>After the internship, she worked as a researcher at Wake Forest School of Medicine in North Carolina.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/amerikansk-forsker-til-nafkam</prop>
     <seg>Etter dette jobbet hun som forsker ved Wake Forest University School of Medicine i North Carolina.</seg>
    </tuv>
   </tu>
   <tu tuid="65" datatype="Text">
    <prop type="score-hunalign">5.31593</prop>
    <prop type="score-bicleaner">0.712</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>Main trends from 2016-2018</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>Hovedtrekk i utviklingen fra 2016-2018</seg>
    </tuv>
   </tu>
   <tu tuid="66" datatype="Text">
    <prop type="score-hunalign">3.13333</prop>
    <prop type="score-bicleaner">0.620</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>&#8226; The five CAM therapies that Norwegians made the most use of in 2018 were (in descending</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>&#8226; De fem alternative behandlingsformene som nordmenn gjorde mest bruk av i 2018, var (i</seg>
    </tuv>
   </tu>
   <tu tuid="67" datatype="Text">
    <prop type="score-hunalign">1.18235</prop>
    <prop type="score-bicleaner">0.624</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/or-outside-box-integrative-healthcare-netherlands</prop>
     <seg>The Dutch Consortium for Integrative Medicine and Health (</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/innenfor-eller-utenfor-boksen-integrativ-behandling-i-nederland</prop>
     <seg>Det nederlandske konsortiet for integrativ medisin og helse (</seg>
    </tuv>
   </tu>
   <tu tuid="68" datatype="Text">
    <prop type="score-hunalign">4.66364</prop>
    <prop type="score-bicleaner">0.600</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>&#8226; This was 1 pp less than in 2016.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>&#8226; Dette var 1 pp f&#230;rre enn i 2016.</seg>
    </tuv>
   </tu>
   <tu tuid="69" datatype="Text">
    <prop type="score-hunalign">2.05951</prop>
    <prop type="score-bicleaner">0.600</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final_210329_%20English_NAFKAM%20strategic%20plan%202021_2025%20%28003%29_0.pdf.converted</prop>
     <seg>Therefore, in 2014 the Finnish Forum for Research in Integrative Medicine and Healthcare (SILF) was established to provide information and facilitate seminars on research in the field of CAM and Integrative Medicine6.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final%20text_210329%20Norwegian%20Strategic%20Plan%202021_2025%20%28002%29_0.pdf.converted</prop>
     <seg>Et finsk forum for forskning i integrativ medisin og helsevesen (SILF) ble opprettet i 2014, for &#229; gi informasjon og legge til rette for seminarer om forskning innen alternativ og integrativ behandling6.</seg>
    </tuv>
   </tu>
   <tu tuid="70" datatype="Text">
    <prop type="score-hunalign">1.625</prop>
    <prop type="score-bicleaner">0.630</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/contact-information/who-collaborating-centre</prop>
     <seg>&#8211; Professor Miek Jong, Director of NAFKAM</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/contact-information/who-samarbeidssenter</prop>
     <seg>- Professor Miek Jong, direkt&#248;r for NAFKAM</seg>
    </tuv>
   </tu>
   <tu tuid="71" datatype="Text">
    <prop type="score-hunalign">1.45444</prop>
    <prop type="score-bicleaner">0.658</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final_210329_%20English_NAFKAM%20strategic%20plan%202021_2025%20%28003%29_0.pdf.converted</prop>
     <seg>In 2019, the commission recommended among others that Swedish citizens should be provided with information on CAM in order to make well-informed choices and they proposed several ways to improve the public's access to independent information on CAM8.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final%20text_210329%20Norwegian%20Strategic%20Plan%202021_2025%20%28002%29_0.pdf.converted</prop>
     <seg>I 2019 anbefalte denne komiteen blant annet at svenske statsborgere burde ha tilgjengelig god informasjon om alternativ behandling for &#229; kunne gj&#248;re velinformerte valg, og komiteen foreslo flere m&#229;ter &#229; forbedre befolkningen tilgang til uavhengig informasjon om dette8.</seg>
    </tuv>
   </tu>
   <tu tuid="72" datatype="Text">
    <prop type="score-hunalign">2.6141</prop>
    <prop type="score-bicleaner">0.576</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>Only a minority (2%) of the CAM users reported experiences with side effects or worsening of</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>&#8226; Kun et mindretall (2%) blant brukerne av alternativ behandling rapporterte at slik behandling</seg>
    </tuv>
   </tu>
   <tu tuid="73" datatype="Text">
    <prop type="score-hunalign">2.66429</prop>
    <prop type="score-bicleaner">0.592</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/lifestyle-changes-during-covid-19-pandemic</prop>
     <seg>To explore possible differences in COVID-19-related lifestyle changes between users and non-users of CAM</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/livsstilsendringer-under-covid-19-pandemien</prop>
     <seg>&#197; utforske mulige forskjeller i COVID-19-relaterte livsstilsendringer mellom brukere og ikke-brukere av alternativ behandling</seg>
    </tuv>
   </tu>
   <tu tuid="74" datatype="Text">
    <prop type="score-hunalign">2.85091</prop>
    <prop type="score-bicleaner">0.622</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/contact-information/who-collaborating-centre</prop>
     <seg>In addition, NAFKAM has collected and analysed country-specific data on the legal status and regulation of TCI in 39 European countries.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/contact-information/who-samarbeidssenter</prop>
     <seg>I tillegg har NAFKAM samlet og analysert landsspesifikke data om juridisk status og regulering av TCI i 39 europeiske land.</seg>
    </tuv>
   </tu>
   <tu tuid="75" datatype="Text">
    <prop type="score-hunalign">1.3</prop>
    <prop type="score-bicleaner">0.608</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/contact-information/who-collaborating-centre</prop>
     <seg>NAFKAM has reviewed the following of WHO benchmarks/technical documents:</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/contact-information/who-samarbeidssenter</prop>
     <seg>NAFKAM har gjennomg&#229;tt f&#248;lgende av WHOs benchmarks/ tekniske dokumenter:</seg>
    </tuv>
   </tu>
   <tu tuid="76" datatype="Text">
    <prop type="score-hunalign">1.87395</prop>
    <prop type="score-bicleaner">0.550</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/american-researcher-nafkam</prop>
     <seg>Dana holds a Master Degree in Public Health from the University of Florida, and completed an internship at the National Institute for Occupational Safety and Health (NIOSH) in Ohio.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/amerikansk-forsker-til-nafkam</prop>
     <seg>Dana har en Master in public health fra University of Florida, og som en del av utdannelsen var hun praktikant ved Institute for Occupational Safety and Health (NIOSH) i Ohio.</seg>
    </tuv>
   </tu>
   <tu tuid="77" datatype="Text">
    <prop type="score-hunalign">4.18163</prop>
    <prop type="score-bicleaner">0.520</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/lifestyle-changes-during-covid-19-pandemic</prop>
     <seg>The results of the study are expected to be published in 2021.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/livsstilsendringer-under-covid-19-pandemien</prop>
     <seg>Resultatene fra studien forventes &#229; bli publisert i 2021</seg>
    </tuv>
   </tu>
   <tu tuid="78" datatype="Text">
    <prop type="score-hunalign">1.01504</prop>
    <prop type="score-bicleaner">0.500</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/neurobiological-basis-manual-therapies-quantitative-sensory-testing-qst-translational</prop>
     <seg>The Neurobiological basis of manual therapies: Quantitative Sensory Testing (QST) as a translational, neurophysiological tool</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/nevrobiologisk-grunnlag-manuelle-terapier-kvantitativ-sensorisk-testing-kst-som-et-translatorisk</prop>
     <seg>Kvantitativ Sensorisk Testing (KST) som et translatorisk, nevrofysiologisk verkt&#248;y.</seg>
    </tuv>
   </tu>
   <tu tuid="79" datatype="Text">
    <prop type="score-hunalign">1.06875</prop>
    <prop type="score-bicleaner">0.538</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/frauke-musial-takes-editor-chief-complementary-medicine-research</prop>
     <seg>Frauke Musial takes on as Editor-in-Chief for "Complementary Medicine Research"</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/frauke-musial-tar-over-som-sjefredaktor-tidsskrift</prop>
     <seg>Frauke Musial tar over som sjefredakt&#248;r for tidsskrift</seg>
    </tuv>
   </tu>
   <tu tuid="80" datatype="Text">
    <prop type="score-hunalign">2.44686</prop>
    <prop type="score-bicleaner">0.620</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/en/or-outside-box-integrative-healthcare-netherlands</prop>
     <seg>) consists of six healthcare and research organizations including the Radboudumc, HagaZiekenhuis, M&#225;xima Medical Center, Rijnstate, Lentis, Louis Bolk Instituut.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/innenfor-eller-utenfor-boksen-integrativ-behandling-i-nederland</prop>
     <seg>) best&#229;r av seks helse- og forskningsorganisasjoner inkludert Radboudumc, HagaZiekenhuis, M&#225;xima Medical Center, Rijnstate, Lentis, Louis Bolk Instituut.</seg>
    </tuv>
   </tu>
   <tu tuid="81" datatype="Text">
    <prop type="score-hunalign">2.0881</prop>
    <prop type="score-bicleaner">0.638</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final_210329_%20English_NAFKAM%20strategic%20plan%202021_2025%20%28003%29_0.pdf.converted</prop>
     <seg>In 2017, the Swedish government assigned a commission to map and submit proposals regarding the use of CAM in relation to patient safety and care in Sweden.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2021-03/Final%20text_210329%20Norwegian%20Strategic%20Plan%202021_2025%20%28002%29_0.pdf.converted</prop>
     <seg>I 2017 ga den svenske regjeringen en komite &#229; kartlegge bruken av alternativ behandling og foresl&#229; tiltak i forhold til pasientsikkerhet og omsorg.</seg>
    </tuv>
   </tu>
   <tu tuid="82" datatype="Text">
    <prop type="score-hunalign">4.06</prop>
    <prop type="score-bicleaner">0.530</prop>
    <prop type="type">1:1</prop>
    <tuv xml:lang="en">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-06/NAFKAM-2018%20report%20EN%20%28002%29_0.pdf.converted</prop>
     <seg>year, may be higher in 2018 than in previous surveys.</seg>
    </tuv>
    <tuv xml:lang="nb">
     <prop type="source-document">https://nafkam.no/sites/default/files/2019-07/NAFKAM-2018%20rapport%20finale%20250619_0.pdf.converted</prop>
     <seg>kan ha v&#230;rt h&#248;yere i 2018 enn i</seg>
    </tuv>
   </tu>
   </body>
</tmx>